Cancer Antibodies Combination Therapies Clinical Research Market Size Insight
05 janv. 2024 07h09 HE
|
KuicK Research
Delhi, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Global Cancer Antibody Combinations Market Opportunity & Clinical Trials Insight 2028 Report Findings & Highlights: Global Cancer Antibody...
Combination Cancer Therapy Clinical Trials Therapies Research Report 2028
09 juin 2022 07h19 HE
|
KuicK Research
Singapore, June 09, 2022 (GLOBE NEWSWIRE) -- Global Combination Cancer Immunotherapy Market Opportunity & Clinical Trials Insight 2028 Report Highlights: Global & Regional Combination...
Combination Cancer Therapy Market Insight 2028
09 juin 2022 05h42 HE
|
KuicK Research
Singapore, June 09, 2022 (GLOBE NEWSWIRE) -- Global Combination Cancer Immunotherapy Market Opportunity & Clinical Trials Insight 2028 Report Highlights: Global & Regional Combination...
Provectus Biopharmaceuticals Expands Global Patent Portfolio to India for Cancer Combination Therapy
09 juin 2020 09h00 HE
|
Provectus Biopharmaceuticals Inc.
2020 India patent follows 2018 India patent that protects Provectus’ proprietary API manufacturing processProvectus further expands cancer combination therapy IP protection by filing new USPTO patent...
PROVECTUS BIOPHARMACEUTICALS EXPANDS GLOBAL PATENT PORTFOLIO FOR CANCER COMBINATION THERAPY
18 avr. 2018 06h00 HE
|
Provectus Biopharmaceuticals Inc.
FOR IMMEDIATE RELEASE KNOXVILLE, TN, April 18, 2018 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, www.provectusbio.com) (“Provectus” or the “Company”), a clinical-stage...